Vor Biopharma (VOR) Equity Ratio (2020 - 2026)

Vor Biopharma (VOR) reported Equity Ratio of 0.3 for Q1 2026, down 149.11% year-over-year from 0.6 in Q1 2025, and up 16.15% on a QoQ basis from 0.35 in Q4 2025.

Vor Biopharma (VOR) has 7 years of Equity Ratio data on file, last reported at 0.3 in Q1 2026.

  • Quarterly Equity Ratio fell 149.11% year-over-year to 0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.3 (down 149.11% YoY) and the FY2025 annual result came in at 0.35, up 47.67% from the prior year.
  • Equity Ratio rose to 0.3 in Q1 2026 per VOR's latest filing, from 0.35 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.84 in Q4 2022 and bottomed at 12.63 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.74 (2024), against an average of 0.72.
  • Peak annual rise in Equity Ratio reached 47.67% in 2025, while the deepest fall reached 2107.69% in 2025.
  • Tracing VOR's Equity Ratio over 5 years: stood at 0.84 in 2022, then retreated by 9.12% to 0.76 in 2023, then sank by 188.92% to 0.68 in 2024, then surged by 47.67% to 0.35 in 2025, then gained by 16.15% to 0.3 in 2026.
  • Per Business Quant, the three latest VOR Equity Ratio figures stand at 0.3 (Q1 2026), 0.35 (Q4 2025), and 12.63 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Vor Biopharma 628.83 Mn 628.83 Mn - -0.30

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.30
Dec 31, 2025 -0.35
Sep 30, 2025 -12.63
Jun 30, 2025 -7.33
Mar 31, 2025 0.60
Dec 31, 2024 -0.68
Sep 30, 2024 0.63
Jun 30, 2024 0.69
Mar 31, 2024 0.74
Dec 31, 2023 0.76
Sep 30, 2023 0.78
Jun 30, 2023 0.81
Mar 31, 2023 0.83
Dec 31, 2022 0.84
Sep 30, 2022 0.77
Jun 30, 2022 0.78
Mar 31, 2022 0.83
Dec 31, 2021 0.89
Sep 30, 2021 0.90
Jun 30, 2021 0.91
Mar 31, 2021 0.91
Dec 31, 2020 -0.78